鴻騰精密拉昇漲超17% 連續第四日反彈
格隆匯3月21日丨鴻騰精密(6088.HK)盤中拉昇一度漲超17%至1.27港元,為連續第四日反彈,股價創3月4日以來新高。鴻騰精密17日晚發佈的業績顯示,2021年營收44.9億美元,同比增4.1%;利潤1.37億美元,同比增219%。中金稱鴻騰精密業績超預期,但考慮到公司2022年整體收入成長性放緩以及1H22傳統消費電子業務需求走弱,下調其目標價37%至1.35港元。另外,瑞信也稱鴻騰精密去年收入勝預期,但欠缺催化劑,持保守看法,維持評級為“中性”,目標價由1.81港元下調至1.15港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.